Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2012
11/28/2012CN101723901B Method for preparing 2-propylbenzimidazole
11/28/2012CN101641350B Dibenzo[b, f][1, 4]oxazapine compounds
11/27/2012US8318953 Reactive coumarin derivatives and their use in cellular analyses
11/27/2012US8318951 Stem cell differentiating agents and uses therefor
11/27/2012US8318944 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/27/2012US8318928 Fused imidazole carboxamides as TRPV3 modulators
11/27/2012US8318791 Substituted imidazole derivatives
11/27/2012US8318777 2-pyridinylethylcarboxamide derivatives and their use as fungicides
11/27/2012US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/27/2012US8318742 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318720 Acrylamide derivatives as Fab I inhibitors
11/27/2012CA2702482C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2702467C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2579002C Pyridyl inhibitors of hedgehog signalling
11/27/2012CA2567662C Compounds and compositions as protein kinase inhibitors
11/27/2012CA2533377C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/27/2012CA2531766C Entry inhibitors of the hiv virus
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2487805C Peptide deformylase inhibitors
11/22/2012WO2012158979A1 Quinazoline-7-ether compounds and methods of use
11/22/2012WO2012158811A2 Purine monophosphate prodrugs for treatment of viral infections
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012158399A1 Condensed 2 - carbamoylpyridazinones as potassium channel modulators
11/22/2012WO2012156467A1 Novel pkc inhibitors
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012156289A1 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012WO2012135112A3 Methods for preparing deuterated 1,2,3-triazoles
11/22/2012US20120296093 Exo- and diastereo- selective synthesis of himbacine analogs
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295928 Methods for detecting and reducing impurities of lapatinib and salts thereof
11/22/2012US20120295923 Aminocyclohexanes and Aminotetrahydropyrans and Related Compounds As Gamma-Secretase Modulators
11/22/2012US20120295920 5-amino-4-hydroxypentoyl amides
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120294809 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
11/22/2012CA2836579A1 Purine monophosphate prodrugs for treatment of viral infections
11/22/2012CA2836311A1 Amine derivatives as potassium channel blockers
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012CA2835735A1 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
11/22/2012CA2834077A1 Inhibitors of bruton's tyrosine kinase
11/21/2012EP2524916A2 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
11/21/2012EP2524914A1 Novel sulfonic acid derivative compound and novel naphthalic acid derivative compound
11/21/2012EP2524913A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
11/21/2012EP2524912A1 Amine derivatives
11/21/2012EP2523948A1 Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
11/21/2012EP2523665A1 Voltage-gated sodium channel blockers
11/21/2012CN1474803B Novel amide derivatives and medicinal use thereof
11/21/2012CN102791720A A process using grignard reagents
11/21/2012CN102791705A Inverse agonists and neutral antagonists for the TSH receptor
11/21/2012CN102791704A Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
11/21/2012CN102791697A Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
11/21/2012CN102791693A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
11/21/2012CN102791691A Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
11/21/2012CN102791690A Di-substituted pyridine derivatives as anticancers
11/21/2012CN102786508A Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method
11/21/2012CN102786485A 2-substituted-2H-1,2,3-triazole derivative and preparation method thereof
11/21/2012CN102786476A Novel compounds as opioid receptor modulators
11/21/2012CN102272126B Optical pure quinazoline compounds
11/21/2012CN101903342B Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
11/21/2012CN101863826B Method for preparing 2-benzyl pyridine compound
11/21/2012CN101490026B 2-oxetanone derivative and process for production thereof
11/21/2012CN101018783B Quinoxaline inhibitors of the HEDGEHOG signalling pathway
11/20/2012US8314242 Process for the preparation of 4-aminobut-2-enolides
11/20/2012US8314155 Bicyclic aromatic sulfinyl derivatives
11/20/2012CA2611530C Tyrosine kinase inhibitors
11/20/2012CA2539975C 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
11/15/2012WO2012154777A1 Hepatitis c virus inhibitors
11/15/2012WO2012154676A1 Partially saturated tricyclic compounds and methods of making and using same
11/15/2012WO2012084852A3 Ectoparasiticidal active substance combinations
11/15/2012WO2012068366A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
11/15/2012US20120289706 Method for Producing Triazolinthione Derivatives and Intermediates Thereof
11/15/2012US20120289701 Forms of lapatinib ditosylate and processes for preparation thereof
11/15/2012US20120289700 Cyclic amine compound and acaricide
11/15/2012US20120289555 Novel S-Nitrosoglutathione Reductase Inhibitors
11/15/2012US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289496 Novel compounds as modulators of protein kinases
11/15/2012US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
11/15/2012US20120288501 Substituted benzazoles and methods of their use as inhibitors of raf kinase
11/15/2012CA2835688A1 Hepatitis c virus inhibitors
11/15/2012CA2835610A1 Proteostasis regulators
11/15/2012CA2835261A1 Partially saturated tricyclic compounds and methods of making and using same
11/14/2012EP2522657A1 Indole derivative
11/14/2012EP2522656A2 Process and Intermediate Compounds Useful in the Preparation of Statins, Particularly Atorvastatin
11/14/2012EP2521549A1 Therapeutic compounds and related methods of use
11/14/2012CN102781934A Thiol detection
11/14/2012CN102781931A 5-alkynyl pyrimidines and their use as kinase inhibitors
11/14/2012CN102781930A Novel anti-platelet agent
11/14/2012CN102781923A 5-alkynyl-pyrimidines
11/14/2012CN102781916A Compounds as bradykinin B1 antagonists
11/14/2012CN102781914A Indole derivative
11/14/2012CN102775396A Modulators of ATP-binding cassette transporters
11/14/2012CN102775395A Preparation method of propiconazole and propiconazole intermediate
11/14/2012CN102775394A Amide compound, its preparation method and application
11/14/2012CN102775393A Preparation method for intermediate of medicine
11/14/2012CN102775386A Preparation method and application of open-ring nitromethylene derivative
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 694